[1]
“In Silico Targeting and Structural Stabilization of LRRC66 by 3′,5,7-Trihydroxy-4′- methoxy flavanone A Computational Strategy for Therapeutic Modulation of Cardiac Remodeling”, Pharmabio., vol. 2, no. 1, pp. 21–35, Aug. 2026, Accessed: Oct. 30, 2026. Available: https://pharmabiologia.com/pharmabiologia/article/view/8